India, Sept. 16 -- Amrutanjan has historically been known for pain-relief products, but the company is now trying to build a broader consumer-health portfolio. Women's hygiene, rehydration, congestion and personal-care products are becoming more important, while management is also investing in manufacturing and distribution to support these categories.

Amrutanjan Health Care was trading at around Rs485, with a market capitalization of roughly Rs1,402 crore. The stock's 52-week range is Rs482.80-774.30, while its P/E is around 22x on current market data.

The stock is therefore much closer to its 52-week low than its high, while its valuation remains below the company's five-year median P/E of around 41x. That does not automatically mean...